QTREX Announces Pricing of a $10 Million Registered Direct Offering of Ordinary Shares
Rhea-AI Summary
QTREX Quantum (Nasdaq: QTEX) entered into a definitive securities purchase agreement with an existing and a new global institutional investor to sell 11,111,111 ordinary shares in a registered direct offering. Gross proceeds are expected to be about $10 million before fees and expenses, with closing anticipated on or about August 21, 2026, subject to customary conditions.
According to QTREX Quantum, net proceeds will be used for working capital and general corporate purposes. A.G.P./Alliance Global Partners is acting as sole placement agent, and the shares are being issued under an effective Form F-3 shelf registration statement via a prospectus supplement and base prospectus filed with the SEC.
Positive
- Registered direct offering to raise gross proceeds of about $10 million
- 11,111,111 ordinary shares placed with existing and new institutional investors
- Use of effective Form F-3 shelf enables relatively quick access to equity capital
Negative
- Issuance of 11,111,111 new ordinary shares implies equity dilution for existing shareholders
- Net cash received will be lower than the stated $10 million gross proceeds due to fees and expenses
News Explained
If the announced offering closes, QTREX Quantum would issue
Market reaction after 10 million registered direct offering: QTEX -24.63% in the Aug 20 session
In the Aug 20 session, QTEX declined 24.63%, reflecting a significant negative market reaction. Argus tracked a trough of -24.5% from its starting point during tracking. Our momentum scanner triggered 30 alerts that day, indicating elevated trading interest and price volatility. Trading volume was exceptionally heavy at 10.1x the daily average, suggesting significant selling pressure.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Aug 19 | technology announcement | Positive | +22.6% | Laser conversion produced graphene-like carbon in all 20 tested conditions. |
| Aug 13 | development program | Positive | -2.8% | Discussions targeted Q4 2026 formalization of a second federal research program. |
| Jul 31 | performance validation | Positive | +8.4% | Printed coaxial platform exceeded strategic partners’ RF qualification requirements. |
| Jul 27 | research collaboration | Positive | +7.8% | Northeastern collaboration granted a first option to negotiate commercial Project IP license. |
| Jul 22 | registration clarification | Neutral | -23.2% | Clarified F-1 resale registration was not a new capital raise. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Three of five recent news events aligned with positive reactions, while two diverged from the reported news direction.
Key Terms
registered direct offering financial
prospectus supplement regulatory
shelf registration statement regulatory
placement agent financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
The financing was led by continued support of an existing institutional investor along with participation from a new global institutional investor
Ness Ziona, Israel, Aug. 20, 2026 (GLOBE NEWSWIRE) -- QTREX Quantum Ltd. (Nasdaq: QTEX) ("QTREX" or the "Company") a company focused on advancing Additively Manufactured Electronics for quantum computing infrastructure, today announced that it has entered into a definitive securities purchase agreement with an existing institutional investor as well as a new global institutional investor for the purchase and sale of 11,111,111 ordinary shares in a registered direct offering (the "Offering"). The gross proceeds to the Company from the Offering are expected to be approximately
The closing of the Offering is expected to occur on or about August 21, 2026, subject to the satisfaction of customary closing conditions. The Company intends to use the net proceeds from the Offering for working capital and general corporate purposes.
The Offering includes continued participation from a prominent global institutional investor alongside a new institutional investor that is part of a well-established global investment management firm with a multi-decade track record.
A.G.P./Alliance Global Partners is acting as the sole placement agent for the Offering.
The ordinary shares are being offered and sold pursuant to a prospectus supplement to be filed with the Securities and Exchange Commission (“SEC”) in connection with a takedown from the Company’s shelf registration statement on Form F-3 (File No. 333-289324), including a base prospectus, previously filed with the SEC on August 6, 2025, as amended on November 25, 2025, which was declared effective by the SEC on December 12, 2025. The Offering is being made only by means of a prospectus supplement and accompanying prospectus which are a part of the effective registration statement. A prospectus supplement and the accompanying prospectus relating to the Offering will be filed with the SEC and will be available on the SEC’s website at www.sec.gov. Additionally, when available, electronic copies of the prospectus supplement and the accompanying prospectus may be obtained from A.G.P./Alliance Global Partners, 590 Madison Avenue, 28th Floor, New York, NY 10022, or by telephone at (212) 624-2060, or by email at prospectus@allianceg.com.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation, or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.
About QTREX Quantum
QTREX Quantum Ltd. (Nasdaq: QTEX) is a technology company focused on advanced connectivity and electronics manufacturing solutions for next-generation hardware markets. Following its acquisition of the AME platform, the Company is developing high-density, thermally optimized quantum connectivity solutions for dilution cryostats and advancing AME applications for defense, aerospace, missile, space, and other mission-critical environments. The Company also continues to advance its medical technology portfolio, including respiratory support and blood monitoring platforms, while actively working to monetize certain parts of the medical business.
For more information, please visit: www.q-trex.com
Forward-Looking Statement Disclaimer
This press release contains express or implied forward-looking statements pursuant to U.S. Federal securities laws. These forward-looking statements are based on the current expectations of the management of the Company only and are subject to factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. For example, the Company is using forward-looking statements when it discusses the receipt and use of proceeds from the Offering; and the filing of a prospectus supplement and the accompanying prospectus relating to the Offering. Except as otherwise required by law, the Company undertakes no obligation to publicly release any revisions to these forward-looking statements. More detailed information about the risks and uncertainties affecting the Company is contained under "Risk Factors" in the Company's annual report on Form 20-F for the fiscal year ended December 31, 2025, filed with the SEC on March 26, 2026.
Company Contact
QTREX Quantum
Email: info@q-trex.com
Phone: +972-9-9664485
Company Contact QTREX Quantum Email: info@q-trex.com Phone: +972-9-9664485